Mahmoud Abdel Rahman

Views:
 
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

Slide 1:

The innovative Swiss pharmaceutical company Area Overview Q1 2011 Name: Mahmoud Abdel Rahman Area: Hofuf

Total Achievement - Value:

Total Achievement - Value 110% 256%

Total Value Strategic Products:

Total Value Strategic Products 110% 219%

Olfen 50 mg lactab Units:

Olfen 50 mg lactab Units 133% 310% M.S = 3.81 National M.S = 6.32 Growth = -47.45 % National Growth = -36.19%

Olfen 100 SR mg Units:

Olfen 100 SR mg Units 78% 168% M.S = 14.08 National M.S = 25.10 Growth = 40.05% National Growth = - 30.56%

Olfen 50 mg Dispersible Units:

Olfen 50 mg Dispersible Units 66% 585% M.S = 4.36 National M.S = 14.85 Growth = ----% National Growth = -25.25%

Gasec 20 mg 14 cap Units:

Gasec 20 mg 14 cap Units 80% 719% M.S = 15.78 National M.S = 16.56 Growth = 63.40% National Growth = 16.46%

Gasec 20 mg 28 cap Units:

Gasec 20 mg 28 cap Units 163% 403%

Gasec 40mg 14caps Units:

Gasec 40mg 14caps Units 111% 74% M.S = 7.65 National M.S = 9.60 Growth = -17.69% National Growth = -1.16%

Gasec40mg 28caps Units:

Gasec40mg 28caps Units 133% 333%

CoAmox 1gm Lactab:

CoAmox 1gm Lactab 93% 89% M.S = 3.29 National M.S = 9.01 Growth = -13.06% National Growth = 27.63%

CoAmox 457mg Susp.:

CoAmox 457mg Susp . 1% -100%

Osteo-mepha Units:

Osteo-mepha Units 11% 1

Uvamin Retard Units:

Uvamin Retard Units 24%

Neurorubine Forte Units:

Neurorubine Forte Units 143% 314% M.S = 29.34 National M.S = 26.32 Growth = 83.79% National Growth = 4.79%

Zamur 250mg tabs Units:

Zamur 250mg tabs Units 174% 1225%

Zamur 500mg tabs Units:

Zamur 500mg tabs Units 125% 445%

Challenges:

Challenges

Opportunities:

Opportunities

Action Plan:

Action Plan

New Ideas:

New Ideas

First Semester Forecast:

First Semester Forecast 102% 1

Thank you for your attention :

The innovative Swiss pharmaceutical company Thank you for your attention